These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2516301)

  • 21. Electrophysiological and Pupillometric Abnormalities in PROM1 Cone-Rod Dystrophy.
    Park JC; Collison FT; Fishman GA; McAnany JJ
    Transl Vis Sci Technol; 2020 Aug; 9(9):26. PubMed ID: 32879782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albinism, or the NOACH syndrome (the book of Enoch c.v. 1-20).
    van Dorp DB
    Clin Genet; 1987 Apr; 31(4):228-42. PubMed ID: 3109790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual acuity and the flash visually evoked cortical potential in albinos.
    Boylan C; Harding GF
    Invest Ophthalmol Vis Sci; 1986 Feb; 27(2):222-5. PubMed ID: 3943945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rod and cone contributions to the dark-adapted 15-Hz flicker electroretinogram.
    Park JC; Cao D; Collison FT; Fishman GA; McAnany JJ
    Doc Ophthalmol; 2015 Apr; 130(2):111-9. PubMed ID: 25579805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The albino chick as a model for studying ocular developmental anomalies, including refractive errors, associated with albinism.
    Rymer J; Choh V; Bharadwaj S; Padmanabhan V; Modilevsky L; Jovanovich E; Yeh B; Zhang Z; Guan H; Payne W; Wildsoet CF
    Exp Eye Res; 2007 Oct; 85(4):431-42. PubMed ID: 17651735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consecutive unilateral recording of the two eyes affects dark-adapted ERG responses, when compared to simultaneous bilateral recording.
    Ross M; Honig H; Ezra-Elia R; Banin E; Obolensky A; Averbukh E; Rosov A; Gootwine E; Ofri R
    Doc Ophthalmol; 2018 Dec; 137(3):183-192. PubMed ID: 30411184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual acuity development in tyrosinase negative oculocutaneous albinism.
    Jacobson SG; Mohindra I; Held R; Dryja TP; Albert DM
    Doc Ophthalmol; 1984 Feb; 56(4):337-44. PubMed ID: 6425027
    [No Abstract]   [Full Text] [Related]  

  • 29. Are albino rats night blind?
    Green DG; Herreros de Tejada P; Glover MJ
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2366-71. PubMed ID: 2071347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual evoked potentials in Negro carriers of the gene for tyrosinase positive oculocutaneous albinism.
    Castle D; Kromberg J; Kowalsky R; Moosa R; Gillman N; Zwane E; Fritz V
    J Med Genet; 1988 Dec; 25(12):835-7. PubMed ID: 3148727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rod-cone dystrophy associated with a rod system electroretinogram obtained under photopic conditions.
    Fishman GA; Peachey NS
    Ophthalmology; 1989 Jun; 96(6):913-8. PubMed ID: 2787013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A form of congenital stationary night blindness with apparent defect of rod phototransduction.
    Peachey NS; Fishman GA; Kilbride PE; Alexander KR; Keehan KM; Derlacki DJ
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):237-46. PubMed ID: 2303327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplitude increase of the multifocal electroretinogram during light adaptation.
    Kondo M; Miyake Y; Piao CH; Tanikawa A; Horiguchi M; Terasaki H
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2633-7. PubMed ID: 10509660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced retinal responses in Huntington's disease patients.
    Pearl JR; Heath LM; Bergey DE; Kelly JP; Smith C; Laurino MY; Weiss A; Price ND; LaSpada A; Bird TD; Jayadev S
    J Huntingtons Dis; 2017; 6(3):237-247. PubMed ID: 28968243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of shorter dark adaptation on ISCEV standard DA 0.01 and DA 3 skin ERGs in healthy adults.
    Hamilton R; Graham K
    Doc Ophthalmol; 2016 Aug; 133(1):11-9. PubMed ID: 27394667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topographical retinal function in oculocutaneous albinism.
    Kelly JP; Weiss AH
    Am J Ophthalmol; 2006 Jun; 141(6):1156-8. PubMed ID: 16765699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albinism. Recent advances.
    Jay B; Carroll W
    Trans Ophthalmol Soc U K (1962); 1980; 100(4):467-71. PubMed ID: 6797109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological Studies on The Dynamics of Luminance Adaptation in the Mouse Retina.
    Joachimsthaler A; Tsai TI; Kremers J
    Vision (Basel); 2017 Oct; 1(4):. PubMed ID: 31740648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albinism in Nigeria with delineation of new recessive oculocutaneous type.
    King RA; Creel D; Cervenka J; Okoro AN; Witkop CJ
    Clin Genet; 1980 Apr; 17(4):259-70. PubMed ID: 6768477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.